Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRACLEER testicular function safety study in male patients with pulmonary arterial hypertension
2004-004391-36Phase 4Completed
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Feb 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of bosentan in pulmonary arterial hypertension (PAH), sponsored by Actelion Pharmaceuticals Ltd. Primary endpoint: Clinically relevant decrease in sperm concentration. Started Feb 2005; status: completed.
02
Drugs
bosentan
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on 2004-004391-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004391-36.